Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mindy L Simpson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Review of Hematology|September 21, 2012
Management of joint bleeding in hemophiliaMindy L Simpson, Leonard A Valentino
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 16, 2021
Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and BNidhi Bhatt, Lisa Boggio, Mindy L Simpson
Journal of Managed Care & Specialty Pharmacy|February 6, 2020
Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII ProductsMindy L Simpson, Vidhi Desai, Géraldine S Maro, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
The Authors RespondMindy L Simpson, Vidhi Desai, Géraldine S Maro, et al.
Journal of Managed Care & Specialty Pharmacy|August 22, 2020
A Real-World Analysis of Commonly Prescribed FVIII Products Based on U.S. Medical Charts: Consumption and Bleeding Outcomes in Hemophilia A PatientsSongkai Yan, Géraldine S Maro, Vidhi Desai, et al.
Advances in Therapy|May 16, 2020
Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc AnalysisShadan Lalezari, Michaël Acquadro, Elodie de Bock, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 21, 2020
Hemophilia: A Review of Perioperative Management for Cardiac SurgeryJenny Kwak, Michael Mazzeffi, Lisa N Boggio, et al.
The Cochrane Database of Systematic Reviews|September 26, 2017
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitorsChatree Chai-Adisaksopha, Sarah J Nevitt, Mindy L Simpson, et al.
Thrombosis and Haemostasis|December 9, 2020
Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 ProphylaxisMaria Elisa Mancuso, Mark T Reding, Claude Negrier, et al.
Journal of Blood Medicine|February 4, 2020
Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic StudyMindy L Simpson, Roshni Kulkarni, Carmen Escuriola Ettingshausen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Review of Hematology|September 21, 2012
Management of joint bleeding in hemophiliaMindy L Simpson, Leonard A Valentino
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 16, 2021
Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and BNidhi Bhatt, Lisa Boggio, Mindy L Simpson
Journal of Managed Care & Specialty Pharmacy|February 6, 2020
Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII ProductsMindy L Simpson, Vidhi Desai, Géraldine S Maro, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
The Authors RespondMindy L Simpson, Vidhi Desai, Géraldine S Maro, et al.
Journal of Managed Care & Specialty Pharmacy|August 22, 2020
A Real-World Analysis of Commonly Prescribed FVIII Products Based on U.S. Medical Charts: Consumption and Bleeding Outcomes in Hemophilia A PatientsSongkai Yan, Géraldine S Maro, Vidhi Desai, et al.
Advances in Therapy|May 16, 2020
Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc AnalysisShadan Lalezari, Michaël Acquadro, Elodie de Bock, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 21, 2020
Hemophilia: A Review of Perioperative Management for Cardiac SurgeryJenny Kwak, Michael Mazzeffi, Lisa N Boggio, et al.
The Cochrane Database of Systematic Reviews|September 26, 2017
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitorsChatree Chai-Adisaksopha, Sarah J Nevitt, Mindy L Simpson, et al.
Thrombosis and Haemostasis|December 9, 2020
Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 ProphylaxisMaria Elisa Mancuso, Mark T Reding, Claude Negrier, et al.
Journal of Blood Medicine|February 4, 2020
Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic StudyMindy L Simpson, Roshni Kulkarni, Carmen Escuriola Ettingshausen, et al.
Pageof 2